US Stock MarketDetailed Quotes
RIGL Rigel Pharmaceuticals
- 13.630
- -0.640-4.48%
Close Oct 31 16:00 ET
- 13.630
- 0.0000.00%
Post 20:01 ET
239.82MMarket Cap-17701P/E (TTM)
14.350High13.571Low91.99KVolume14.120Open14.270Pre Close1.28MTurnover0.63%Turnover RatioLossP/E (Static)17.59MShares17.30052wk High-8.02P/B200.71MFloat Cap7.48452wk Low--Dividend TTM14.73MShs Float1147.499Historical High--Div YieldTTM5.46%Amplitude6.400Historical Low13.916Avg Price1Lot Size
About Rigel Pharmaceuticals Company
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.
Company Profile
SymbolRIGL
Company NameRigel Pharmaceuticals
Listing DateNov 29, 2000
Issue Price7.00
Founded1996
CEOMr. Raul R. Rodriguez
MarketNASDAQ
Employees147
Fiscal Year Ends12-31
Address611 Gateway Boulevard,Suite 900
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1985
Phone1-650-624-1100
Websitehttp://www.rigel.com
Company Executives
- Name
- Position
- Salary
- Raul R. Rodriguez
- Director, President and Chief Executive Officer
- 3.44M
- David A. Santos
- Executive Vice President and Chief Commercial Officer
- 1.34M
- Raymond J. Furey
- Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
- 683.00K
- Dean L. Schorno
- Executive Vice President and Chief Financial Officer
- 1.21M
- Gregg Anthony Lapointe, C.P.A.,M.B.A.
- Chairman of the Board
- 190.58K
- Dr. Walter H. Moos,PhD
- Independent Director
- 138.58K
- Kamil Ali-Jackson, Esq.
- Independent Director
- 140.58K
- Jane Wasman, J.D.
- Independent Director
- 145.58K
- Dr. Alison L. Hannah, M.D.
- Independent Director
- 212.98K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data